SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001021408-01-504316
Filing Date
2001-08-01
Accepted
2001-08-01 00:00:00
Documents
3
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.txt 10-Q 59368
3 SIXTH AMENDMENT TO LOAN AGREEMENT dex10169.txt EX-10.169 11750
4 EMPLOYMENT AGREEMENT DATED JULY 9, 2001 dex10170.txt EX-10.170 17719
  Complete submission text file 0001021408-01-504316.txt   90566
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 1695041
SIC: 8731 Services-Commercial Physical & Biological Research